Effect of Mild Hepatic Impairment (Child-Pugh Class A) on the Single-dose Pharmacokinetics of Istradefylline
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2016
Price : $35 *
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Kyowa Hakko Kirin
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 20 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 26 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.